Christian Mueller
Corporate Officer/Principal at IMMUTEP LIMITED
Christian Mueller active positions
Companies | Position | Start | End |
---|---|---|---|
IMMUTEP LIMITED | Corporate Officer/Principal | - | - |
Chief Tech/Sci/R&D Officer | 31/12/2017 | - | |
General Counsel | 31/12/2017 | - |
Career history of Christian Mueller
Former positions of Christian Mueller
Companies | Position | Start | End |
---|---|---|---|
Medical Enzymes AG
Medical Enzymes AG Medical/Nursing ServicesHealth Services Medical Enzymes AG is a privately held innovative biopharmaceutical company with a focus on therapeutically useful enzymes. The company has developed a new product family based on amino acid depleting enzymes. This unique approach is highly effective against cancer - the major target market of Medical Enzymes AG. Medical Enzymes business strategy focuses on the clinical development of therapeutic enzymes until clinical proof of concept and to commercialize those products through collaboration with selected pharmaceutical partners. | Corporate Officer/Principal | - | - |
Training of Christian Mueller
Technical University of Berlin | Graduate Degree |
Statistics
International
Germany | 3 |
Australia | 2 |
Operational
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 1 |
General Counsel | 1 |
Sectoral
Health Technology | 2 |
Health Services | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
IMMUTEP LIMITED | Health Technology |
Private companies | 1 |
---|---|
Medical Enzymes AG
Medical Enzymes AG Medical/Nursing ServicesHealth Services Medical Enzymes AG is a privately held innovative biopharmaceutical company with a focus on therapeutically useful enzymes. The company has developed a new product family based on amino acid depleting enzymes. This unique approach is highly effective against cancer - the major target market of Medical Enzymes AG. Medical Enzymes business strategy focuses on the clinical development of therapeutic enzymes until clinical proof of concept and to commercialize those products through collaboration with selected pharmaceutical partners. | Health Services |
- Stock Market
- Insiders
- Christian Mueller
- Experience